R. Gersh

PRECEDENT: A randomized phase II trial comparing EC145 and pegylated liposomal doxorubicin (PLD) in combination, versus PLD alone, in subjects with platinum-resistant ovarian cancer.

R. Burger, E. Sausville, R. Coleman, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hematologic response to three alternative dosing schedules of azacitidine in patients with myelodysplastic syndromes.

J. Hainsworth, T. Cosgriff, A. Cohn, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

α-Difluoromethylornithine as Treatment for Metastatic Breast Cancer Patients

J. O’Shaughnessy, Stephen E. Jones, L. Demers, 1999 .

Alpha-difluoromethylornithine as treatment for metastatic breast cancer patients.

J. O’Shaughnessy, S. Jones, L. Demers, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

PRECEDENT: a randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum-resistant ovarian cancer.

R. Burger, E. Sausville, R. Coleman, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a Phase II, randomized, noncomparative study

C. Obasaju, D. Richards, L. Wilfong, 2011, Investigational New Drugs.

High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer

W. Nichols, P. Weiden, W. Bensinger, 1998, Bone Marrow Transplantation.

An open-label, multicenter, phase II study of AT-101 in combination with rituximab (R) in patients with untreated, grade 1-2, follicular non-Hodgkin's lymphoma (FL).

L. Leopold, D. Richards, L. Garbo, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.